ramirez I, Vera Z, Mastroianni P, Maciel O, Maidana M, Marin L, et al. Benefits of a National Program for Adverse Drugs Reactions (ADRS) Surveillance in Diabetic Patients. J. Drug Delivery Ther. [Internet]. 2022 Aug. 15 [cited 2026 Feb. 1];12(4-S):40-2. Available from: https://jddtonline.info/index.php/jddt/article/view/5618